Landi D. Continuation of natalizumab versus interruption is associated with lower risk of relapses during pregnancy and postpartum in women with MS. Abstract 338. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
TOP-subsidie voor onderzoek naar vroege hersenafwijkingen Alzheimer
feb 2019 | Dementie